Vitalhub (TSE:VHI – Free Report) had its price target increased by Cormark from C$7.50 to C$8.00 in a report issued on Tuesday, BayStreet.CA reports.
Separately, Canaccord Genuity Group raised their price objective on Vitalhub from C$7.50 to C$8.00 and gave the company a buy rating in a research note on Monday, May 13th.
View Our Latest Stock Report on VHI
Vitalhub Trading Up 5.0 %
Vitalhub (TSE:VHI – Get Free Report) last posted its quarterly earnings data on Thursday, May 9th. The company reported C$0.04 earnings per share (EPS) for the quarter, missing the consensus estimate of C$0.07 by C($0.03). The company had revenue of C$15.26 million during the quarter, compared to the consensus estimate of C$14.12 million. Vitalhub had a net margin of 8.66% and a return on equity of 5.78%. As a group, equities research analysts forecast that Vitalhub will post 0.2700115 earnings per share for the current fiscal year.
Vitalhub Company Profile
Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.
See Also
- Five stocks we like better than Vitalhub
- What is the Dogs of the Dow Strategy? Overview and Examples
- Top 5 High-Performance Cryptocurrency ETFs to Watch
- What is the FTSE 100 index?
- 3 Stocks That Plummeted After the Post-Fed Speech Crash
- How Can Investors Benefit From After-Hours Trading
- Adobe Stock: It’s Not Too Late To Buy The Dip
Receive News & Ratings for Vitalhub Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitalhub and related companies with MarketBeat.com's FREE daily email newsletter.